WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000026372) MYOSIN HEAVY CHAIN HOMOLOG
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/026372    International Application No.:    PCT/US1999/026177
Publication Date: 11.05.2000 International Filing Date: 05.11.1999
Chapter 2 Demand Filed:    01.06.2000    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: INCYTE PHARMACEUTICALS, INC. [US/US]; 3174 Porter Drive, Palo Alto, CA 94304 (US) (For All Designated States Except US).
TANG, Y., Tom [CN/US]; (US) (For US Only).
CORLEY, Neil, C. [US/US]; (US) (For US Only).
GORGONE, Gina, A. [US/US]; (US) (For US Only).
GUEGLER, Karl, J. [CH/US]; (US) (For US Only).
BAUGHN, Mariah, R. [US/US]; (US) (For US Only)
Inventors: TANG, Y., Tom; (US).
CORLEY, Neil, C.; (US).
GORGONE, Gina, A.; (US).
GUEGLER, Karl, J.; (US).
BAUGHN, Mariah, R.; (US)
Agent: BILLINGS, Lucy, J.; Incyte Pharmaceuticals, Inc., 3174 Porter Drive, Palo Alto, CA 94304 (US)
Priority Data:
60/172,248 05.11.1998 US
09/187,060 05.11.1998 US (Priority Withdrawn 02.03.2000)
Title (EN) MYOSIN HEAVY CHAIN HOMOLOG
(FR) HOMOLOGUE DE CHAINE LOURDE DE MYOSINE
Abstract: front page image
(EN)The invention provides a human myosin heavy chain homolog (MHCH) and polynucleotides which identify and encode MHCH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of MHCH.
(FR)L'invention concerne un homologue de chaîne lourde de myosine humaine (MHCH) ainsi que des polynucléotides identifiant et codant pour MHCH. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne également des méthodes de diagnostic, de traitement ou de prévention de troubles associés à l'expression de MHCH.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)